ArticleVeterinary research2026
Residue 188 of the Hexon protein governs FAdV-4 pathogenicity by activating PINK1/Parkin-mediated mitophagy.
Article in Veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Fowl adenovirus serotype 4 (FAdV-4) infection causes significant economic losses to the global poultry industry. Viruses often hijack host cellular machinery to facilitate their replication; however, the mechanisms by which FAdV-4 manipulates host pathways remain poorly defined. Mitochondria, the central hubs for energy metabolism and innate immunity in hepatocytes and cardiomyocytes, are critical targets for viral manipulation, yet their role in FAdV-4 pathogenesis remains unexplored. Here, we demonstrated that FAdV-4 infection caused direct mitochondrial damage and induced PINK1/Parkin-dependent mitophagy both in vitro and in vivo. Moreover, the virus actively hijacked the PINK1/Parkin-mediated mitophagy to enhance viral replication in LMH cells. Inhibition of mitophagy led to an average tenfold reduction in viral replication of pathogenic FAdV-4 in LMH cells (p < 0.05). Strikingly, residue 188 in the Hexon protein, a key virulence determinant, differentially regulated mitophagy: the R188I mutation in the pathogenic FAdV-4 attenuated mitophagy, whereas the I188R mutation in nonpathogenic FAdV-4 enhanced this process. This study elucidated the viral exploitation of mitophagy by FAdV-4 to promote viral replication, and established Hexon residue 188 and the mitophagy pathway as prime targets for developing novel therapeutics against avian adenoviral diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.